BioGenerator-backed Wugen, which has raised $200M+ in VC funding, launches clinical trial for cancer drug

› St. Louis Business Journal

On TV: President Biden’s Cancer Moonshot is Expected to Fund Innovative Treatments in St. Louis

› HEC-TV

The Brookings Institution: St. Louis is a 'Rising Star'

› Brookings Institution

BioGenerator Company Susterco and Impossible Sensing Enter Licensing Agreement

2022 Startups to Watch: BioGenerator Companies Make the List

› St. Louis Business Journal

Women in Leadership: BioGenerator's Anjie Sanford

BioGenerator backs 18 startups with $3.3M investment, plots 'aggressive' funding strategy for 2022

› St. Louis Business Journal

BioGenerator Ventures Invests $3.3 Million in 18 Bioscience Companies; Portfolio Tops $2B in Follow-on Capital

BioGenerator receives grant from Wells Fargo to 'jump start' new agriculture venture

› St. Louis Business Journal